BL
BIO icon

BFSG LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

BFSG LLC’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.7K Hold
237
– – 0.01% 406
2026
Q1 		$66.2K Hold
237
– – 0.01% 401
2025
Q4 		$71.9K Hold
237
– – 0.01% 376
2025
Q3 		$66.6K Hold
237
– – 0.01% 385
2025
Q2 		$57.3K Hold
237
– – 0.01% 378
2025
Q1 		$57.8K Hold
237
– – 0.01% 363
2024
Q4 		$78K Hold
237
– – 0.01% 341
2024
Q3 		$79.4K Hold
237
– – 0.01% 353
2024
Q2 		$64.9K Hold
237
– – 0.01% 346
2024
Q1 		$82.1K Hold
237
– – 0.01% 339
2023
Q4 		$76.7K Buy
+237
New +$74.3K 0.01% 323
2020
Q1 		– Sell
-1,800
Closed -$666K – 153
2019
Q4 		$666K Buy
+1,800
New +$635K 0.13% 133

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BFSG LLC's BIO Position: Q2 2026 in Review

BFSG LLC held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 237 shares worth $69.7K. The position accounts for 0.01% of the portfolio, ranked #406.

BFSG LLC first reported a position in BIO in Q4 2019 and has held it in 12 quarters since. The position peaked at $666K in Q4 2019. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • BFSG LLC held 237 shares of Bio-Rad Laboratories Class A worth $69.7K as of Q2 2026.
  • BFSG LLC left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up 0.01% of BFSG LLC's portfolio in Q2 2026, its #406 holding.
  • BFSG LLC first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and has held it in 12 quarters since.
  • BFSG LLC's Bio-Rad Laboratories Class A position peaked at $666K in Q4 2019.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.